Skip to main navigation

Skip to main content

About
Our Story Our People
Science
Pipeline Izokibep Lonigutamab Presentations & Publications
Community
Patients Partnerships
Investors & Media
Overview Press Releases Events & Presentations Financials & Filings Corporate Governance Email Alerts Investor Resources Media Resources
Careers
Stories

Contact Us

Events & Presentations

Presentations

November 13, 2024

Corporate Presentation 6.4 MB

March 20, 2024

Lonigutamab Phase 1/2 PoC Data in TED 1.8 MB

March 11, 2024

Izokibep Phase 2b Long-Term 32-Week Data in HS 824.7 KB

Upcoming Events

There are no upcoming events available at this time.

Past Events

Jefferies London Healthcare Conference

Nov 16, 2023 9:00 AM GMT

ACELYRIN, INC. 3Q23 Earnings Call

Nov 7, 2023 4:30 PM EST

21st Annual Morgan Stanley Global Healthcare Conference

Sep 13, 2023 11:30 AM EDT

HS Top-Line Data Readout

Sep 11, 2023 5:30 PM EDT

ACELYRIN, INC. 2Q23 Earnings Call

Aug 14, 2023 4:30 PM EDT

Pagination

First page
Previous page
Page 1
Current page 2

Email Alerts
RSS Feeds
Contact Investor Relations
Contact Media Relations

Building an innovative biopharma company that invests in, develops and commercializes life-changing drug therapies.

Get company updates to your inbox

green arrow icon

Sitemap

About Science Community Investors & Media Careers Stories Contact Us

Headquarters

4149 Liberty Canyon Rd
Agoura Hills, CA 91301

South San Francisco Office

651 Gateway Blvd, 6th Floor
South San Francisco, CA 94080

Social Media

^©2024 ACELYRIN, INC. All Rights Reserved. | ACELYRIN and the ACELYRIN logo are trademarks of ACELYRIN, INC.

Privacy Policy |
Terms |
|

Facebook
Twitter
LinkedIn
Email Page